Evidence map›Paper›PMID 41595551›Full record

ArticleBiomedicines2025

Pentraxin 3 as a Modulator of miRNAs and Extracellular Vesicles Release in Triple-Negative Breast Cancer Cells.

Diogo Gomes da Costa, Fábio Ribeiro Queiroz, Flávia Santiago de Oliveira, Angelo Borges de Melo Neto, Marina Malheiros Araújo Silvestrini, Ludmila Rodrigues Pinto Ferreira, Isabela Aurora Rodrigues, Virgínia Mendes Russo Vallejos, Adriana Oliveira Costa, Frédéric Frézard and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Diogo Gomes da CostaDepartment of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0009-0005-5251-2723
Fábio Ribeiro QueirozTranslational Oncology Research Laboratory, Teaching, Research and Innovation Center, Mário Penna Institute, Belo Horizonte 30380-420, Brazil.ORCID 0000-0003-0238-5787
Flávia Santiago de OliveiraDepartment of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0009-0008-1429-6101
Angelo Borges de Melo NetoPatos de Minas Campus, Federal University of Uberlândia, Patos de Minas 38701-002, Brazil.ORCID 0000-0003-0978-2355
Marina Malheiros Araújo SilvestriniOswaldo Cruz Foundation (Fiocruz Minas), René Rachou Institute, Belo Horizonte 30190-002, Brazil.ORCID 0000-0001-7641-3360
Ludmila Rodrigues Pinto FerreiraDepartment of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0001-9944-6691
Isabela Aurora RodriguesDepartment of Clinical and Toxicological Analyses, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0003-4047-7148
Virgínia Mendes Russo VallejosDepartment of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0003-3505-9494
Adriana Oliveira CostaDepartment of Clinical and Toxicological Analyses, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-1793-3013
Frédéric FrézardDepartment of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0003-3783-5717
Jorge Gomes Goulart FerreiraTranslational Oncology Research Laboratory, Teaching, Research and Innovation Center, Mário Penna Institute, Belo Horizonte 30380-420, Brazil.
Matheus de Souza GomesPatos de Minas Campus, Federal University of Uberlândia, Patos de Minas 38701-002, Brazil.ORCID 0000-0001-7352-3089
Andréa Teixeira-CarvalhoOswaldo Cruz Foundation (Fiocruz Minas), René Rachou Institute, Belo Horizonte 30190-002, Brazil.ORCID 0000-0003-2814-5183
Paulo Guilherme de Oliveira SallesTranslational Oncology Research Laboratory, Teaching, Research and Innovation Center, Mário Penna Institute, Belo Horizonte 30380-420, Brazil.ORCID 0000-0001-8839-3491
Letícia da Conceição BragaDepartment of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-6181-9410
Adriana Abalen Martins DiasDepartment of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0001-9415-3240

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível superior (CAPES) 88887.508772/2020-00Coordenação de Aperfeiçoamento de Pessoal de Nível superior (CAPES) 88887.688041/2022-00Programa Nacional de Apoio à Atenção Oncológica (PRONON) - Ministério da Saúde (MS) NUP 25000.020618/2019-35
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerEVsPentraxin 3TNBCtriple-negative breast cancer

Identifiers

PMID41595551
PMCPMC12838261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.